Daniel T. Ginat to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Daniel T. Ginat has written about Dose-Response Relationship, Drug.
Connection Strength
0.031
-
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Ann Oncol. 2019 02 01; 30(2):297-302.
Score: 0.031